Microstructural Cues for the Treatment of Heart Failure
治疗心力衰竭的微观结构线索
基本信息
- 批准号:10078623
- 负责人:
- 金额:$ 39.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-15 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute myocardial infarctionAddressAdultAffectAlginatesAmericanAmericasAnatomyAnimal ModelAnimalsBiochemicalBiocompatible MaterialsBiological Response Modifier TherapyBiopolymersCardiacCardiac MyocytesCardiac developmentCardiomyopathiesCardiovascular systemCathetersCause of DeathCell CommunicationCell Culture TechniquesCellsChronicCicatrixClinicalClinical ResearchCollagenComplementary therapiesCoronary heart diseaseCuesDepositionDevelopmentDiagnosisDoseDown-RegulationDrug Delivery SystemsEFRACEchocardiographyElementsEngineeringExtracellular MatrixExtracellular Matrix ProteinsFibroblastsFormulationGelGene ExpressionGenetic TranscriptionGeometryGoalsHealthHeartHeart DiseasesHeart InjuriesHeart failureHypertrophyImmunofluorescence MicroscopyIn SituIn VitroIndividualInfarctionInjectableInjectionsMeasuresMechanicsMedicalMedicineMicrofabricationMissionModelingMyocardialMyocardial InfarctionMyocardiumNational Heart, Lung, and Blood InstituteNatural regenerationPathogenicityPathway interactionsPatientsPeptidesPlayPolymersPopulationPre-Clinical ModelPrognosisPropertyRattusRecoveryRegenerative capacityResearchRodent ModelRoleShapesStructureSupport SystemSystemTechniquesTestingTherapeuticTherapeutic EffectThickTissuesVascular blood supplyVascularizationVentricularangiogenesisbasecardiac regenerationcardiac repairclinical applicationdesigndisabilityeffective therapyheart functionimprovedimproved outcomein vivoin vivo regenerationinjuredinsightischemic cardiomyopathyischemic injurymechanotransductionmortalitymyocardial injurypreventrepairedresponsestem cell deliverythree dimensional cell culturetranslational approachvascular bed
项目摘要
Project Summary/Abstract
Acute myocardial infarction (MI) is complicated by the subsequent development of scar tissue leading to
chronic cardiac insufficiency. Unfortunately, the lack of treatments for this maladaptive fibrotic response often
leads to a poor prognosis. Early attempts at stem cell delivery and biological therapeutics to address this
problem have been promising, but inconsistent. To meet this challenge, the Desai lab, with collaborators, has
developed a unique system of randomly dispersed polymeric microstructures, termed microrods, that have
been found to decrease fibroblast proliferation and promote cardiomyocyte hypertrophy in vitro. The objective
of this proposal is to study the mechanisms of interaction between microrods and cardiac fibroblasts in vitro
and in an animal models of infarct. We will also examine the effect of microstructures on cardiac remodeling.
This will enable the design of more effective therapies to prevent the development of cardiac scar tissue and
encourage recovery of heart function after MI. Based on previous studies and recent research on the
mechanical microenvironment, it is hypothesized that primary adult ventricular fibroblasts will respond to the
presence of microrods with a unique set of transcriptional changes in pathways relevant to
mechanotransduction, micro-environmental interaction, and extracellular matrix (ECM) deposition. In Aim 1,
quantitative analyses of changes in gene expression and immunofluorescence microscopy will be used to
examine cellular interactions with microrods in 3D culture. Specifically, quantification of ECM down-regulation
and mechanotransductive interactions will elucidate the mechanisms of effect of microstructures on fibroblasts.
In addition, HepIII conjugated microrods will be developed in order to augment vascularization, another key
element of cardiac regeneration. Aim 2 will use quantitative biochemical and immunohistochemical techniques
in an established rat model of MI to test the hypothesis that microrod injection into the infarct zone will produce
similar transcriptional changes in markers of the fibrotic response as seen in vitro through interaction with the
cardiac fibroblast population, as well as angiogenesis produced with the addition of HepIII to the microrods.
Finally, Aim 3 will evaluate the therapeutic benefit of injected microrods in the setting of chronic ischemic
cardiomyopathy as suggested by preliminary in vivo results. Therapeutic effect after microrod injection will be
measured by serial echocardiograms to assess ejection fraction and cardiac anatomy in relation to the infarct
scar and angiogenesis. By decreasing fibrotic scarring, inducing angiogenesis and promoting myocardial
regeneration, injectable microrods will contribute to improving outcomes after MI. Understanding these
mechanisms will lead to the design and optimization of complementary therapies and drug delivery
possibilities, which will further the NHLBI's mission of treating heart disease to enhance the health of all
individuals so that they can live longer and more fulfilling lives.
项目摘要/摘要
急性心肌梗塞(MI)随后发生疤痕组织的发展使
慢性心脏不足。不幸的是,这种不良适应性纤维化反应缺乏治疗方法
导致预后不佳。早期尝试干细胞输送和生物疗法解决这一问题
问题一直很有希望,但不一致。为了应对这一挑战,Desai实验室与合作者有
开发了一种独特的系统,该系统是随机分散的聚合微结构,称为微脚架,具有
发现在体外降低成纤维细胞增殖并促进心肌细胞肥大。目标
该建议是研究微棒与心脏成纤维细胞之间相互作用的机制
并在梗塞动物模型中。我们还将检查微结构对心脏重塑的影响。
这将使设计更有效的疗法的设计,以防止心脏疤痕组织的发展和
鼓励在MI后恢复心脏功能。基于以前的研究和最近的研究
机械微环境,假设原发性成人心室成纤维细胞会对
存在与与途径相关的唯一转录变化的微型模型的存在
机械转导,微环境相互作用和细胞外基质(ECM)沉积。在AIM 1中,
基因表达和免疫荧光显微镜变化的定量分析将用于
检查3D培养中与微棒的细胞相互作用。具体而言,ECM下调的定量
机械转移的相互作用将阐明微观结构对成纤维细胞的作用机理。
此外,将开发HEPIII共轭微码以增强血管化,这是另一个关键
心脏再生元素。 AIM 2将使用定量的生化和免疫组织化学技术
在已建立的MI大鼠模型中,以检验以下假设,即在
通过与与纤维化反应的标记的标记相似的转录变化,如通过与
心脏成纤维细胞种群以及在微脚架上添加HEPIII产生的血管生成。
最后,AIM 3将在慢性缺血的情况下评估注射微型棒的治疗益处
体内初步结果所建议的心肌病。微型注射后的治疗作用将是
通过连续超声心动图测量,以评估相对于梗死的射血分数和心脏解剖学
疤痕和血管生成。通过减少纤维化疤痕,诱导血管生成并促进心肌
再生,可注射的微脚架将有助于改善MI后的结局。了解这些
机制将导致互补疗法和药物输送的设计和优化
可能性,这将进一步促进NHLBI治疗心脏病的使命,以增强所有人的健康
个人,以便他们可以生活更长,更充实的生活。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lipid signaling affects primary fibroblast collective migration and anchorage in response to stiffness and microtopography.
- DOI:10.1002/jcp.26236
- 发表时间:2018-04
- 期刊:
- 影响因子:5.6
- 作者:Mkrtschjan MA;Gaikwad SB;Kappenman KJ;Solís C;Dommaraju S;Le LV;Desai TA;Russell B
- 通讯作者:Russell B
Injectable hyaluronic acid based microrods provide local micromechanical and biochemical cues to attenuate cardiac fibrosis after myocardial infarction.
- DOI:10.1016/j.biomaterials.2018.03.042
- 发表时间:2018-07
- 期刊:
- 影响因子:14
- 作者:Le LV;Mohindra P;Fang Q;Sievers RE;Mkrtschjan MA;Solis C;Safranek CW;Russell B;Lee RJ;Desai TA
- 通讯作者:Desai TA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tejal A. Desai其他文献
Insights from an AIMBE Workshop: Diversifying Paths to Academic Leadership
AIMBE 研讨会的见解:学术领导力的多元化路径
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Beth l. Pruitt;N. Chesler;Rena Seltzer;O. Eniola;S. Margulies;M. Campo;Scott I. Simon;M. Grimm;Sarah Mandell;Andrew Alleyne;Jennifer L. West;Tejal A. Desai - 通讯作者:
Tejal A. Desai
The Effects of Personal Pharmacogenetic Testing on the Effects of Pharmacy Student Perceptions of Knowledge and Attitudes Towards Precision Medicine
个人药物遗传学测试对药学学生对精准医学的知识认知和态度的影响
- DOI:
10.1101/052043 - 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Dalga Surofchy;Sam S. Oh;J. Galanter;Pin Xiang;Megan Li;Su Guo;Tejal A. Desai;J. Guglielmo;K. Giacomini;J. Long;A. Wu;E. Burchard - 通讯作者:
E. Burchard
Control of Cardiomyocyte Adhesion and Organization by Microscale Topographical Cues
- DOI:
10.1016/j.bpj.2009.12.2183 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Anuj A. Patel;Matthew G. Chown;Rahul G. Thakar;Tejal A. Desai;Sanjay Kumar - 通讯作者:
Sanjay Kumar
Tejal A. Desai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tejal A. Desai', 18)}}的其他基金
Regulation of epithelial function using targeted nanowires
使用靶向纳米线调节上皮功能
- 批准号:
10453894 - 财政年份:2022
- 资助金额:
$ 39.97万 - 项目类别:
Regulation of epithelial function using targeted nanowires
使用靶向纳米线调节上皮功能
- 批准号:
10677028 - 财政年份:2022
- 资助金额:
$ 39.97万 - 项目类别:
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
ACE2 靶向 PET 放射性示踪剂用于研究 SARS-CoV-2 器官损伤和治疗反应的时空分布。
- 批准号:
10391190 - 财政年份:2021
- 资助金额:
$ 39.97万 - 项目类别:
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
ACE2 靶向 PET 放射性示踪剂用于研究 SARS-CoV-2 器官损伤和治疗反应的时空分布。
- 批准号:
10681427 - 财政年份:2021
- 资助金额:
$ 39.97万 - 项目类别:
UCSF/UCB Joint Graduate Group in Bioengineering
UCSF/UCB 生物工程联合研究生小组
- 批准号:
10089723 - 财政年份:2021
- 资助金额:
$ 39.97万 - 项目类别:
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
ACE2 靶向 PET 放射性示踪剂用于研究 SARS-CoV-2 器官损伤和治疗反应的时空分布。
- 批准号:
10490883 - 财政年份:2021
- 资助金额:
$ 39.97万 - 项目类别:
Mechanisms of nanostructure-enhanced transepithelial drug delivery
纳米结构增强的跨上皮药物递送机制
- 批准号:
9085108 - 财政年份:2014
- 资助金额:
$ 39.97万 - 项目类别:
Mechanisms of nanostructure-enhanced transepithelial drug delivery
纳米结构增强的跨上皮药物递送机制
- 批准号:
8748142 - 财政年份:2014
- 资助金额:
$ 39.97万 - 项目类别:
Mechanisms of nanostructure-enhanced transepithelial drug delivery
纳米结构增强的跨上皮药物递送机制
- 批准号:
8929244 - 财政年份:2014
- 资助金额:
$ 39.97万 - 项目类别:
Mechanisms of nanostructure-enhanced transepithelial drug delivery
纳米结构增强的跨上皮药物递送机制
- 批准号:
9298652 - 财政年份:2014
- 资助金额:
$ 39.97万 - 项目类别:
相似国自然基金
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长链非编码RNA MIPRL在急性心肌梗塞中的作用及分子机制
- 批准号:81870275
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Cdx2+胎盘干细胞移植治疗急性心肌梗塞的实验研究
- 批准号:81270281
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
LPA在急性心梗诱发心律失常中的作用及其电生理机制
- 批准号:81170163
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
心肌缺氧/再灌注与细胞移植多功能集成微流控芯片模型构建及应用
- 批准号:21175107
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Mindfulness and Behavior Change to Reduce Cardiovascular Disease Risk in Older People with HIV
正念和行为改变可降低老年艾滋病毒感染者的心血管疾病风险
- 批准号:
10762220 - 财政年份:2023
- 资助金额:
$ 39.97万 - 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:
10712202 - 财政年份:2023
- 资助金额:
$ 39.97万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 39.97万 - 项目类别:
Long-term exposure to arsenic, and the co-occurrence of uranium, in public and private drinking water: associations with cardiovascular and chronic kidney diseases in the California Teachers Study
公共和私人饮用水中长期接触砷以及同时存在铀:加州教师研究中与心血管和慢性肾脏疾病的关联
- 批准号:
10677410 - 财政年份:2023
- 资助金额:
$ 39.97万 - 项目类别:
3D Bioprinting of a Bioelectric Cell Bridge for Re-engineering Cardiac Conduction
用于重新设计心脏传导的生物电细胞桥的 3D 生物打印
- 批准号:
10753836 - 财政年份:2023
- 资助金额:
$ 39.97万 - 项目类别: